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INVESTING IN HEALTH AND MARKET REGULATION IN 
THE EUROPEAN HEALTHCARE SYSTEMS 
E. Shipkovenska, Tz. Vodenicharov, M. Dyakova 
 
 
 
THEORETICAL BACKGROUND 
 Investing in health – an ethical necessity or economic demand 
Health is already widely accepted as a basic human necessity and right. The aspiration for 
good health is natural and leading in almost every human being. At the beginning of the 
21st century the World Health Report 2000 was issued “Health systems: improving 
performance”. Despite the controversial and much discussed analyses and comparisons of 
different countries’ healthcare systems, it draws the attention to the cost of ill health or 
illness – not only physical and psychological, but also social and economic (1): “… illness 
itself… can threaten people’s dignity and their ability to control what happens to them… 
Health systems have a responsibility not just to improve people’s health, but to protect 
them against the financial cost of illness…” It stresses on the state’s responsibility for 
investing in health and preventing economic losses due to unexpected disease. 
The role of health as a driver of economic growth has been recently acknowledged 
in Europe. It’s already considered to be of great importance for the commitment of 
Europe's governments to make Europe the most competitive and dynamic knowledge 
driven economy by 2010 (2). Several years ago, the Commission on Macroeconomics and 
Health concluded that ill health was contributing to the low level of economic growth in 
poor countries. The report showed that investment in health interventions would lead to 
substantial economic growth (3). Despite increasing recognition of the link between health 
and economic development in low-income countries, the relationship has received 
attention in rich countries as well (4). Nevertheless reasons for investing in health in rich 
countries may differ in detail from that in low-income countries, there is considerable and 
convincing evidence that significant economic benefits can be achieved by improving 
health not only in developing, but also in well-developed economies. In spite of the 
remaining evidence gaps policy-makers in developed countries should consider investing 
in health as one (of few) ways by which to achieve their economic objectives (4). 
Several mechanisms, falling into four main categories, could account for the 
relation between the population health status and national economic growth (5):  
− Productivity. Healthier populations tend to have higher labour productivity, because 
their workers are in good physical and mental condition. They also suffer fewer lost 
workdays.  
− Education. Healthier people who live longer have stronger incentives to invest in 
developing their skills, which promotes greater productivity and, in turn, higher 
income. Good health also promotes school attendance and enhances cognitive 
function.  
− Investment in physical capital. Longer life-expectancy creates a need for savings for 
retirement. Increased savings lead to increased investment.  
− “Demographic dividend." Transition from high to low rates of mortality and fertility 
in many developing countries in recent decades. This gradually gives way to an 
increase in the proportion of the population that is of working age. Income per capita 
can rise dramatically, if people are engaged into productive employment.  
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Thus the design of the national healthcare system and the financial resources 
allocated to its development and improvement appears to be crucial for population health, 
which on its side has a major influence on the economic growth of certain country. Every 
health system has developed on its own way, influenced by cultural, historical, social, 
economic and technical factors. Grounded on this, the healthcare in the European countries 
differs mainly in two aspects: 
1. The financing mechanisms: types of health provision (insurance) models, payment 
mechanisms, revenue distribution etc; 
2. The regulation of the healthcare services and market development: public – private 
balance and level of entrepreneurship regulation. 
 
 
 
 Basic financial principles and challenges in the European  health 
systems 
A health system is complex structure, consisting of people, institutions, and organizations, 
which interact to mobilize and allocate resources for prevention and treatment of diseases 
and injuries. This structure is based on certain fundamental pillars - essential elements that 
enable the healthcare system to function: information, management, human resources, and 
financing (6). In the present paper we shall discuss only aspects of the forth pillar – 
healthcare financing. 
 The European countries organize, govern, manage and finance their healthcare 
systems in different ways, but all of them are based on few common principles: 
1. Universal access to medical care; 
2. Solidarity in the distribution of resources and expenditures; 
3. High standard (quality and safety) of healthcare services. 
 
 
 The challenge of healthcare financing is twofold: to mobilize sufficient funds for 
the health system and to apply (manage) those funds well (6). Mobilizing funds to finance 
public health interventions is difficult both because health services are becoming more and 
more costly and because raising revenues in low- and middle-income countries is not easy. 
Choices of different financing mechanisms also have important implications for that who 
will bear the costs of health care: the population at large may share spending; thereby 
providing effective insurance to those who become ill, or it may fall most heavily on the 
sick ones. There are also a number of initiatives to promote health insurance coverage 
through voluntary schemes. Strong arguments can be made in favour of pooling the 
financial risk associated with paying for health care among the widest population possible, 
effectively paying for the health care of the poor and the sick with taxes and premiums 
paid by those who are healthier and wealthier. 
 
There are two main financial sources in healthcare:  
− Public: state (governmental, semi-state) / insurance / mixed; 
− Private: out-of-pocket (official and unofficial) / private insurance / mixed. 
 
Private health insurance exists in a number of countries and is most often used as 
supplemental or complementary. In Denmark, Germany, Greece and the United Kingdom, 
many patients use private health insurance so they can be treated by the physician of their 
choice or escape waiting in patients’ lists in the public sector. The available empirical 
evidence shows that income is the key parameter in the decision to buy additional health 
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insurance and not health status or “need”. High premiums may make it impossible for poor 
patients to buy private health insurance and this problem is further exacerbated if 
premiums are risk-based where less healthy individuals, who are disproportionately poorer, 
pay more. However, in most countries, due to the fact that insurance is often bought in 
group settings, premiums remain more or less independent of health status and may 
therefore remain affordable for large groups of the population (6). 
The process of financing and provision of health services can be simplified into two 
inter-related and complementary processes – transfer and exchange: 
− The providers transfer health resources (products) to the patients (customers); 
− The patient’s transfer (exchange) financial resources towards the providers – directly 
or through a third party (insurer). 
 
The relation between the financing and the health results (outcome) can be resumed 
in figure 1 (7).  
 
 
 
Figure 1. Influence of healthcare financing on the outcome (7) 
 
Demographic change in Europe presents further economic, budgetary and social 
challenges in coming decades due to people living longer and a potential drop in the 
workforce from the falling birth rate. While in many ways this can be seen as a triumph for 
public health, it also poses a particular challenge for the health and social sector. 
Predictions are that the ratio of elderly, economically inactive people (> 65 years) to 
people of working age could more than double between 2005 to 2050 in the European 
Union. It is more important than ever that people remain healthy and independent to as late 
in life as possible, so that premature deaths among the middle-aged working population are 
avoided and morbidity is “compressed” towards the end of life. As a result of these 
tendencies, in the last decade, most of the European health systems, especially in well-
developed market economies, are characterized by an increasing financial deficit, despite 
the considerable amount of resources allocated for healthcare. The gap between the health 
expenditure and health resources is increasing due to mostly three main factors (7):  
− Aging of the population and epidemiological transition to chronic, life-long 
morbidity,  
− Fast development of health science and technology and 
− Incompetent health policy, governance and management. 
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Facing this constant increase in the financial deficit, governments worldwide are 
facing the dilemma: increase in the resources (revenues) or restriction of the expenditures. 
In general, there are two mechanisms possible (8): 
First option: increase in the revenues – insurance contributions, co-payments, fees, 
taxes etc. This can eventually lead to decrease in the number of insured people, especially 
in systems with voluntary health insurance. 
Second option: restrict the resources for medical care. This may eventually cause 
decrease in the quality of health services and in the human capacity in health.  
When taking decision on investing in healthcare and distribution and re-distribution 
of resources and spending, we should not forget that the provider of health services is 
mainly aiming at profit while the user (patient / customer) is orientated towards higher 
utility (effective care) (8). The goal of all European countries is achieving balance between 
profit and utility (fig. 2). 
 
 
 
Figure 2. Balance between profit and utility in the health sector (8) 
 
In general, the challenges for the European health systems can be summarized 
as follows: 
1. The costs of medical care increasing more than costs in other social and economic 
sectors - scientific innovations, information, communication, diagnostic and 
treatment technologies etc; 
2. Excessive demand of health services by the population: 
− increased life expectancy and aging; 
− increased awareness, education, expectations; 
− increased income and financial stability of the population. 
3. Free market and competition is not a reasonable option for a healthcare system; 
4. Difficulties in maintaining solidarity principle and universal access to healthcare; 
5. Difficulties in maintaining high quality and safety of health services; 
6. Free movement of goods, services, people and capital in the EU. 
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Regulation, entrepreneurship and market development in healthcare 
„If it moves, tax it. 
If it still moves, regulate it. 
If it stops moving, subsidize it“ 
Ronald Reagan 
 
The 1990s witnessed a dramatic upsurge in the scale, character and calibre of 
entrepreneurial initiatives within European health care systems (9). A wide variety of 
market-inspired efforts to stimulate service innovation, including increased quality and 
greater efficiency, have been launched in both public and not-for-profit private sectors, and 
in core health service activities as well as in more peripheral supplies and services. In 
practice, the last 10 years have been a period of substantial organizational reconfiguration 
in the health sector, and increased entrepreneurial activity has been at the core of that 
process of change (10,11). 
Entrepreneurial behaviour is perceived to stimulate innovation and initiative. The 
conceptual and practical emphasis on entrepreneurialism can have a positive impact on 
health systems when the changes undertaken help strengthen the ability of national policy-
makers to achieve their stated policy objectives (12). At the organizational level, 
entrepreneurialism seeks to modernize and rationalize organizations to increase their 
operating efficiency. The powerful impetus to innovate generated by entrepreneurialism 
can have decidedly less positive effects, however, when it has not been adequately fenced 
in by effective state regulation. Entrepreneurs inevitably seek to segment markets so as to 
exploit profitable niches, while publicly accountable regulators try to ensure that the entire 
market is served efficiently and affordably (12). 
Health care has a unique character as a social as well as a private good, which 
increases the importance of the regulatory role in the health sector. What is obvious from 
the last decade developments in European health systems is that a substantial volume of 
new regulation has been generated. Most European countries established new types, as 
well as expanded the existing range, of what can be termed steer-and-channel regulation. 
Thus, as areas of entrepreneurial activity grew, they were accompanied by a parallel 
growth in related state regulation. At present, the state is expected to ‘row less but steer 
more’, its role in driving the health sector forward has to increase in scale, scope and 
sophistication. The state’s supervisory responsibilities have evolved to the point that the 
term ‘stewardship’ has now been applied to its overall policy and management obligations 
in the health sector (13). The concept of stewardship obliges the state to steer overall health 
system activity in an ethically grounded as well as a financially efficient manner. 
Regulation, as a central instrument of stewardship, must from this perspective similarly 
satisfy these two basic requirements calling for ethical and efficient state behaviour. 
Failing to regulate entrepreneurialism adequately in the health sector would be a serious 
breech of the state’s role as a responsible steward (9). 
 
 
The mechanisms of regulation 
Despite wide-ranging definitions and contradictory rationales, there is broad agreement 
about the source and general mechanisms of regulation. Regarding who regulates, we can 
find national level as well as regional and local levels of administration. With the 
emergence of new pan-European agencies, European Union regulation can also be 
supranational. While most regulation in Europe is conducted by some form of government 
department, it can be undertaken by independent regulatory agencies or by self-regulatory 
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bodies (9). Regulation to ensure health gain necessarily addresses actors outside as well as 
inside health care and intersectoral collaboration is a necessary tool for successful 
regulation. The mechanisms of regulation can be grouped into three basic categories, tools 
and strategies, which can in turn be combined in various mixes (9). The major categories 
are legislation, administrative decree and judicial order, one for each of the three branches 
of government (legislative, executive and judicial). Each of these three can be generated in 
many different forms and formats, particularly administrative decrees (advisory 
regulations, guidelines, etc).  
 
 
Two dimensions of health sector regulation (9): 
1. Social and economic policy objectives. It is normative and value-driven in 
nature, concerned with specific policy goals and with the broad public interest (which may 
be different in different countries). These broad policies also need to influence government 
decisions in other sectors such as education, transport, employment, housing and 
agriculture (14). These objectives are: 
− Equity and justice: to provide equitable and needs-based access to health care for 
the whole population, including poor, rural, elderly, disabled and other 
vulnerable groups; 
− Social cohesion: to provide health care through a national health care service or to 
install a social health insurance system; 
− Economic efficiency: to contain aggregate health expenditures within financially 
sustainable boundaries; 
− Health and safety: to protect workers, to ensure water and food safety; 
− Informed and educated citizens: to educate citizens about clinical services, 
pharmaceuticals and healthy behaviour; 
− Individual choice: to ensure choice of provider, and in some cases insurer, as much 
as possible within the limits of the other objectives. 
 
2. Health sector management mechanisms. This level is practical and operational 
and is concerned with the specific regulatory mechanisms through which decision-makers 
seek to attain the type of policy objectives set out (9). These means are largely technical in 
nature, concerning efficient and effective management of both human and material 
resources: 
− Regulating quality and effectiveness: assessing cost-effectiveness of clinical 
interventions; training health professionals; accrediting providers; 
− Regulating patient access: gate-keeping; co-payments; general practitioner lists; 
rules for subscriber choice among third-party payers; tax policy; tax subsidies; 
− Regulating provider behaviour: transforming hospitals into public firms; regulating 
capital borrowing by hospitals; rationalizing hospital and primary care/home care 
interactions; 
− Regulating payers: setting rules for contracting; constructing planned markets for 
hospital services; developing prices for public-sector health care services; 
introducing case-based provider payment systems (e.g. diagnostic-related groups); 
regulating reserve requirements and capital investment patterns of private insurance 
companies etc;  
− Regulating pharmaceuticals: generic substitution; reference prices; profit controls; 
basket-based pricing; positive and negative lists; 
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− Regulating physicians: setting salary and reimbursement levels; licensing 
requirements; setting malpractice insurance coverage. 
 
 
 Rules of the regulatory road (9): 
 Regulate strategically 
− Regulation is part of strategic planning; 
− Regulation is a means rather than an end; 
− Regulation should further core social and economic policy objectives; 
− Regulation is long-term not short-term. 
 
 Regulate complexly 
− Regulation involves multiple issues simultaneously, 
− Regulation can combine mechanisms from competing disciplines, 
− Regulation requires an integrated approach that coordinates multiple 
mechanisms, 
− Regulation should fit contingencies of each health system, 
− Regulation requires flexible public management. 
 
 No deregulation without re-regulation 
− Deregulation requires a new set of regulatory rules, 
− Re-regulate before you deregulate. 
 
 Trust but verify 
− Regulation requires systematic monitoring and enforcement, 
− Self-regulation requires systematic external monitoring and enforcement. 
 
 
Regulatory approaches in the health sector (9) 
Regulating capacity 
Many countries have adopted some form of regulation aimed at limiting the capacity of the 
health system.  
 
 Regulating prices 
Regulation can also be aimed at prices in the health system, for example by using centrally 
determined fees or differential payments such as the diagnosis related group (DRG) 
method. Government can also use ‘price’ regulation in the health insurance sector by 
regulating contributions, premiums and risk-adjustment mechanisms as well as the terms 
under which such insurance is provided. 
 
 Regulating quality 
Government can also regulate the health sector through the collection and dissemination of 
information on provider performance.  A different aspect of quality of care that can be 
regulated is implementation of patients’ rights.  
 
 Regulating market structure and levels of service 
Regulation often takes the form of establishing the ‘rules of the game’ for the participants 
in the health system. Most prominently, this involves establishing conditions for entry into 
health markets and setting levels of service. One method of regulating the incentive to 
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‘cream skim’ is to offer health insurers per capita payments (e.g. capitation) adjusted for 
the risk of each enrolled citizen. The prevalence of such practices depends on the incentive 
structure offered by government and, in particular, on the level of actual risk-sharing. On 
the other hand, governments may have less success monitoring so-called ‘quality 
skimping’, in which chronically ill and elderly patients fail to receive adequate care (15). 
 
 Regulating entitlements 
Once citizens are covered, the entitlements available to them may be subject to government 
regulation. Many countries are struggling with the issue of determining a package of health 
services that sick funds are obliged to provide. In addition, various supplementary 
insurance policies may be available for services not covered under national health 
insurance. This raises perplexing problems of differentiating between what is provided and 
how it is provided under the different schemes. This is another example of how difficult it 
can be to develop and apply regulations aimed at supplementary insurance.  
 
 We can summarize five major forms of regulation, found in European 
countries: 
− Decentralization; 
− Compulsory self-regulation; 
− Accreditation and licensing; 
− Independent regulatory institutions; 
− Regulation through inter-sect oral collaboration. 
 
 Who is regulating? Regulatory organs: 
− Parliament; 
− Governmental institutions (Ministry of health, National Institutes); 
− Independent regulatory bodies (Accreditation, audit agencies; professional 
organizations etc); 
− EU structures (European Commission); 
− Courts; 
− Self-regulation. 
 
In terms of the conceptual framework outlined above, it could be said that health 
systems have been moving from control by standardization of professional norms, to 
various forms of command-and-control, and on to attempts to standardize outputs and 
evaluate outcomes. Moving away from command-and-control, however, did not 
necessarily mean less regulation. The evolution of regulation in the health sector, therefore, 
is not a matter of a linear progression from one mechanism of control to the next, but rather 
a constant mixing and remixing of regulatory tools that have accumulated throughout the 
years of a health system’s development (9).  
We can also suggest that most European healthcare systems will achieve a slower 
but steady growth in the number of social entrepreneurs, working in the public sector but 
importing a variety of private sector concepts and incentives. Policy-makers would become 
more and more comfortable with this situation. There should be a noticeable increase in 
what was termed ‘social entrepreneurialism’ (16). This middle territory between purely 
bureaucratic public and purely for-profit private may itself blur the public-private 
boundaries by incorporating, elements of not-for-profit private in partnership with 
independently managed public-sector organizations. In such system the regulatory 
challenges will be considerable, and successful outcomes will depend on the evolution of 
strict regulatory arrangements. One potential regulatory framework that has yet to be 
 10 
adequately explored in the health sector is the application of the notion of independent 
regulatory agencies (9). As the overall entrepreneurial level increases within health 
systems, the range, scope and capacity of state regulation will have to increase with it. The 
challenge to policy-makers will be to concentrate on designing a better framework with 
which to conduct that supervision.  
 
The state and the market in European healthcare: 
1. The European Union analyses regarding the benefit and damage from the free market 
competition in health care are contradictory. 
2. The market competition in health care requires strict regulation through specific 
legislation. 
3. The final goal of the market regulation in healthcare is to assure that every decision 
and initiative taken is in the public (social) interest. 
4. The mixed public-private model of healthcare is evaluated as the most efficient way 
for reorganization of the European health systems. 
5. The future belongs to a market-orientated, patient-centred healthcare system. 
6. One of the most effective ways to achieve better health for the whole population, in 
conditions of restricted resource, is through health promotion and preventive 
medicine. 
7. The long-term experiences of certain countries as well as international analyses 
suggest that the choice for a health insurance model should be made on: 
− The level of economic development of the country; 
− The level of the social moral values and ethics; 
− The level of political responsibility to health issues; 
− The tested models in international experiences. 
 
 
 
CASE STUDY 
 Healthcare financing and reforms in Bulgaria on the way to a 
 modern market-orientated health system 
 General introduction and context 
In the period since 1989, the countries of south-eastern Europe have invested significant 
efforts in the pursuit of wide-ranging reform of their health sectors, addressing issues of 
financing, organization and management of health care services. These efforts were a 
reaction to the inadequacies of the health systems inherited from the communist era, the 
pressures arising from political and economic transition, a collapse in the funding available 
for health care and, to differing degrees, the effects of wars, conflicts and economic 
sanctions. While the countries have followed different trajectories, their overall aims in the 
health sector have often been similar in the process of reform. With the exception of the 
former Yugoslavia, all the SEE countries followed the Semashko model of health care 
provision developed in the USSR in the 1920s, till the 1990s. In the 1990s, health funding 
collapsed in all countries of the region (17).  
 
 Transition in health financing and system in Bulgaria during the 
 process of reform (18) 
In general, the health care reforms in Bulgaria were aimed at changing the health system 
financing methods in order to: ensure sufficient and sustainable health care budget; 
guarantee equity in the public health sector; enhance efficiency and quality of services; 
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reorganize primary health care and rationalize outpatient and inpatient facilities. The health 
reform remained on the periphery of public sector reform until the late 1990s and little 
changed until 1997. The health insurance system was introduced in 1998 when the Health 
Insurance Act was adopted, introducing compulsory and voluntary health insurance. The 
contributions were set at 6% of an individual’s income, shared between the employer and 
employee at a ratio of 80:20. The State and the municipalities cover the contributions of 
pensioners, children and low-income groups. The Health Insurance Act defines direct 
patient co-payments for using health care services covered by the basic benefits package. 
Since 2000, patients pay 1% of the minimum monthly salary for each outpatient visit and 
2% of the minimum monthly salary per day of hospitalization, up to 10 bed-days per year. 
The compulsory health insurance system guarantees a basic benefits package of health care 
services to the insured population; however, this package is not clearly specified, which 
creates financial burden for the population. Health care financing was separated from 
health care provision, and contract-based relations were established. Private practice was 
legalized in 1991, public and private health care facilities were reorganized. Financial 
reforms were followed by change in the payments to hospital sector providers and the 
introduction of a scheme based on performance and cases – “clinical pathways” with a 
single flat rate per diagnosis. The change in hospital financing was supposed to enhance 
the competition between the health care providers and increase the quality of services. The 
primary care and GPs as gatekeepers to specialized care were introduced, allowing cost-
containment, but also opening a discussion of whether such policies would hinder the free 
provision and access to health care. Total health expenditure has been increasing since 
1998. It accounted for 7.7% of GDP in 2004, i.e. it was higher than the 6.8% average of the 
EU10 countries (19). However, there was a general decline in levels of public health 
expenditure, accompanied by a relative increase in private sources from 34.6% in 1999 to 
45.5% of total health financing in 2003 (20).  
 Contribution-based financing of health care has not been able to provide enough 
funding for the system. The fact that 1 million people do not pay their contributions results 
less resources for the NHIF. In order to cope with these difficulties the contribution rate is 
planned to be increased and the ratio of employer: employee contributions is intended to 
reach 50:50 by 2009, in order to provide disincentives for the employer to escape paying 
contributions, conceal the real income of employees or not to hire new workers. However, 
at the same time, the planned initiative led to a discussion of whether this might create 
additional financial burden for the population and public dissatisfaction with the health 
system (18). 
 
The way forward – opportunities to improve the financing of Bulgarian 
healthcare system and open a way to more efficient public-private mix 
system 
The analysis of the Bulgarian healthcare financial status reveals chronic lack of resources 
for health and considerable number of cases of ineffective and inexpedient management of 
the spent financial resources. Considering the restricted state budget as well as the NHIF 
incapacity to provide enough finances for the routine activities of the healthcare system, a 
multifaceted strategy has to be accepted in order to solve the problems of the Bulgarian 
healthcare. It needs to find new sources and approaches for collecting the necessary funds 
for healthcare. The specific circumstances in Bulgaria require the introduction of an up-to-
date and efficient healthcare financing, which would be able to provide balance and 
stability in the system at the present situation. Some of the most important prerequisites for 
this are (21): 
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1. Surrounded by a constantly changing social, political and economic environment, 
the Bulgarian people are trying to protect themselves and their families, considering health 
protection on first place. 
2. In correspondence to the widely discussed and already implemented in many 
European countries Theory of Human Capital, the working force with higher social and 
health status has higher productivity. 
3. Every company and organization would logically prefer to direct certain amount of 
money for the health of its employees, instead of compulsory paying these amounts as 
taxes to the state. This payment could be part of the collective labour agreement, which 
requires respective changes in the taxation legislation system. 
4. The policy of the Ministry of Health for savings at all costs in the medical 
establishments is equalizing the economic effectiveness with the medical effectiveness, 
which is unfavourable for the patient. In this case the patient should pay the difference, 
which leads to decrease in the formal income of the medical staff.  
 
 
Basic principles of the suggested approach (21) 
1. Defining a basic package of health services, obligatory covered by the NHIF. 
2. Free choice of health services and benefits for the population. 
3. Free choice of health insurance fund for supplementary health insurance. 
4. Financing of the primary health care, based on the number of actually registered 
insured and for services done. 
5. Free (liberal) hospital prices. The fees should be officially announced by the hospital 
board. The part, covered by the NHIF basic package should be indicated as well as 
the amount of the additional payment. The prices vary in certain limits, set by the 
professional organizations and the state for every year. 
6. Free choice of medical establishment by the patient on the basis of quality and price. 
7. Regulation of the hospital capacity in response to the health services requirement. 
8. Pluralism in the options for and ratio public/private mix, formulated in the health 
strategy of the Ministry of health as well as by the market necessities. 
9. Implementation of DRG financing system in the hospitals, aiming at provision of real 
funds for real expenses. 
10. Competition among the different medical establishments. 
 
 
 Basic concept of the financial model (21) 
The model foresees the increase of the health insurance contribution, through 
implementation of an elaborated three-pillar model, as follows: 
− Mandatory basic health insurance, provided by the NHIF as existing at present. 
− Mandatory supplementary health insurance, covering the so-called “extended 
package” of health services and benefits, provided by the NHIF or another licensed 
HIF. 
− Voluntary health insurance, covering the “VIP package” of health services and 
benefits.  
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Conclusion 
The chance for Bulgaria is to implement a specific for the country health insurance model, 
in which its own experience as well as that of other European countries has been 
integrated. The further reforms in the health system should be taken with long-term 
responsibility by the decision-makers, based on clear evidence, multi-sectoral and 
international consultations and wide public debate.  
 
 
EXERCISES 
Task 1 
The students (divided in groups of 3 to 5) are asked to make comparison between the 
healthcare systems and their financing between two different European countries. The 
comparison is presented according to several indicators (criteria) in the form of power 
point presentation. A discussion is opened afterwards. By doing so, it is possible to 
distinguish common challenges for the future as well as areas where a greater effort needs 
to be made in some countries of the region than in others. 
 
Task 2 
The students should make a SWOT analysis of their own country’s healthcare system and 
propose a possible Action plan for improvement, especially in economic terms. 
 
Task 3 
The students are asked to search (through recommended readings and internet) for different 
sustainable possibilities for private entrepreneurship in their own healthcare system. A 
brainstorming is made to point out the strengths and weaknesses of any of them. 
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